Interesting, thanks for the insights. I do like the new strategy they have taken with daigou, being less reliant on one major reseller. It means any market share gains they take from here are likely more sustainable and the risk is diversified somewhat. The new label launch was good timing for resetting the company's relationship with the resellers IMO.
That and David B seemed to signal that English label was the area in which we would see more product innovation soon (due to the lack of need to for regulatory approval for every new product / formulation). The A2 Platinum product range is very slim compared to most competitors.
Goldman Sachs, page-8
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.59 |
Change
0.070(1.07%) |
Mkt cap ! $4.764B | |||
| Open | High | Low | Value | Volume |
| $6.56 | $6.67 | $6.55 | $10.14M | 1.534M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13624 | $6.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.60 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |